ميمپارا

Riik: Iisrael

keel: araabia

Allikas: Ministry of Health

Toimeaine:

CINACALCET HYDROCHLORIDE 30 MG

Saadav alates:

AMGEN EUROPE B.V.

ATC kood:

H05BX01

Ravimvorm:

FILM COATED TABLETS

Manustamisviis:

PER OS

Valmistatud:

AMGEN EUROPE B.V., NETHERLANDS

Terapeutiline rühm:

CINACALCET

Näidustused:

Treatment of secondary hyperparathyrodism (HPT) in patients with end-dtage renal disease (ESRD) on maintenance dialysis therapy. Mimpara may be used as part of a therapeutic regimen including phosphate binders and/or Vitamin D sterols, as appropriate. Reduction of hypercalcaemia in patients with parathyroid carcinoma.

Loa andmise kuupäev:

2012-10-01